International Collaborations

  • T-Cell 2.0 – observational international registry of patients with newly diagnosed peripheral T-cell lymphoma.
  • Global NLPHL One Working Group (GLOW) Initiative
  • Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Current Projects

  • Movember cancer registries platform
  • Adolescent and young adult, Waldenström macroglobulinemia, testicular lymphoma projects
  • Immunoglobulin use and outcomes in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma – The ICAN Study
  • Long-term outcomes in patients with SMZL treated in the Rituximab Era (now recruiting)
  • Real-world Experience of Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B Cell Lymphoma
  • RT Inhibitor Study – Influence of anti-retroviral prophylaxis on outcomes after R-CHOP chemotherapy in DLBCL  (now recruiting)

Completed Projects

  • GELF criteria project
  • A review of the patterns of treatment and survival outcomes for patients with large B-cell lymphoma in Australia
  • Chronic Lymphocytic Leukaemia data analysis (Scholarly Intensive Placement for Medical Students)
  • Melbourne Genomics Health Alliance Lymphoma Flagship
  • Ibrutinib follow-up named patient program (NPP) analyses for CLL and MCL
  • WhiMSICAL – Waldenstrӧm Macroglobulinaemia Study Involving Cart-wheeL


The Australasian Lymphoma Alliance (ALA)

The ALA has been in a long-term research partnership with the LaRDR. We value our collaboration with the ALA.

HoLISTIC: Hodgkin Lymphoma International Study for Individual Care

HoLISTIC is a current LaRDR project looking to optimise patient care.

T-cell Project 2.0

The T-cell Project 2.0 is a current LaRDR project looking to improve understanding of Peripheral T-cell lymphoma.










De-identified registry data may be requested by completing a project proposal and data access form and be accompanied by relevant ethics committee certification. Investigators who intend to publish their work but with limited financial resources could contact the registry manager for a publication cost support form. The application will be considered on a case-by-case basis.

Requests from contributing clinicians, staff and academic organisations will be fulfilled without charge.  External requests will be considered by the LaRDR and may incur a fee.

For questions please contact us at